PETV (PetVivo Holdings) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 12, 2026)


PETV PetVivo Holdings Inc PETV
31 GF Score
Price $0.80
GF Value $0.51
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is PetVivo Holdings 5-Year Yield-on-Cost %?

PetVivo Holdings PETV 31 5-Year Yield-on-Cost % is 0.00 as of Jul. 12, 2026. GuruFocus rates PETV with a GF Score™ of 31/100 and a GF Value™ of $0.51 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 327 Medical Devices & Instruments companies, PetVivo Holdings ranks worse than 305810.09% on this metric.

PetVivo Holdings's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for PetVivo Holdings's 5-Year Yield-on-Cost % or its related term are showing as below:



PETV's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.35
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

PetVivo Holdings  (OTCPK:PETV) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


PetVivo Holdings 5-Year Yield-on-Cost % Related Terms


PETV vs ARAY, RDGL, NSPR: 5-Year Yield-on-Cost % Comparison

For the Medical Devices subindustry, PetVivo Holdings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PetVivo Holdings 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PetVivo Holdings's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where PetVivo Holdings's 5-Year Yield-on-Cost % falls into.


PETV
31GF Score
PetVivo Holdings Inc PETV
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PetVivo Holdings 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of PetVivo Holdings is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
PetVivo Holdings (PETV) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 12, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on PetVivo Holdings and its competitors. According to the industry distribution chart, PetVivo Holdings ranks #999999 out of 327 companies in the Medical Devices & Instruments industry.
Is PetVivo Holdings' 5-Year Yield-on-Cost % too high?
PetVivo Holdings' current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, PetVivo Holdings ranks #999999 out of 327 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, PetVivo Holdings has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PetVivo Holdings' 5-Year Yield-on-Cost % compare to ARAY and RDGL?
According to the Medical Devices & Instruments industry distribution chart, PetVivo Holdings ranks #999999 out of 327 companies for 5-Year Yield-on-Cost %. This places PetVivo Holdings in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.35, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on PetVivo Holdings and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PetVivo Holdings's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetVivo Holdings stock overvalued right now?
Based on GuruFocus' analysis, PetVivo Holdings (PETV) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.51, compared to a current price of $0.80 — trading 56.9% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. PetVivo Holdings' overall GF Score™ is 31/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For PetVivo Holdings (PETV), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PetVivo Holdings (PETV) Overvalued in 2026?

Based on GuruFocus' analysis, PetVivo Holdings stock appears to be overvalued. The current stock price of $0.80 is trading 56.9% above its estimated GF Value™ of $0.51. GuruFocus considers PetVivo Holdings to be Significantly Overvalued.

Key valuation signals for PETV:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $0.51 vs. price of $0.80 (56.9% above fair value)
  • GF Score™: 31/100 with 6 warning signs

No single metric tells the full story. See the PETV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PetVivo Holdings Business Description

Address 5151 Edina Industrial Boulevard, Suite 575, Edina, MN, USA, 55439
PetVivo Holdings Inc is an emerging biomedical device company. It is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of several patents. The company has also begun the commercialization of its product Spryng with OsteoCushion technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses.
31GF Score

Get the complete analysis for PETV

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.80
Price
$0.51
GF Value